Interdisciplinary Decision Making in Hemorrhagic Stroke Based on CT Imaging—Differences Between Neurologists and Neurosurgeons Regarding Estimation of Patients' Symptoms, Glasgow Coma Scale, and National Institutes of Health Stroke Scale by Wagner, Andrea et al.
ORIGINAL RESEARCH
published: 26 September 2019
doi: 10.3389/fneur.2019.00997
Frontiers in Neurology | www.frontiersin.org 1 September 2019 | Volume 10 | Article 997
Edited by:
Yves Vandermeeren,
CHU Dinant Godinne UCL
Namur, Belgium
Reviewed by:
Candice Delcourt,
George Institute for Global
Health, Australia
Robbert-Jan Van Hooff,
University of Copenhagen, Denmark
J. Geraldo R. Vaz,
Cliniques Universitaires
Saint-Luc, Belgium
*Correspondence:
Andrea Wagner
andrea.wagner@
klinik.uni-regensburg.de
Specialty section:
This article was submitted to
Stroke,
a section of the journal
Frontiers in Neurology
Received: 09 May 2019
Accepted: 02 September 2019
Published: 26 September 2019
Citation:
Wagner A, Schebesch K-M,
Isenmann S, Steinbrecher A,
Kapapa T, Zeman F, Baldaranov D,
Grauer O, Backhaus R, Linker RA and
Schlachetzki F (2019) Interdisciplinary
Decision Making in Hemorrhagic
Stroke Based on CT
Imaging—Differences Between
Neurologists and Neurosurgeons
Regarding Estimation of Patients’
Symptoms, Glasgow Coma Scale,
and National Institutes of Health
Stroke Scale. Front. Neurol. 10:997.
doi: 10.3389/fneur.2019.00997
Interdisciplinary Decision Making in
Hemorrhagic Stroke Based on CT
Imaging—Differences Between
Neurologists and Neurosurgeons
Regarding Estimation of Patients’
Symptoms, Glasgow Coma Scale,
and National Institutes of Health
Stroke Scale
Andrea Wagner 1*, Karl-Michael Schebesch 2, Stefan Isenmann 3, Andreas Steinbrecher 4,
Thomas Kapapa 5, Florian Zeman 6, Dobri Baldaranov 1, Oliver Grauer 7, Roland Backhaus 8,
Ralf A. Linker 1 and Felix Schlachetzki 1
1Department of Neurology, University of Regensburg, Regensburg, Germany, 2Department of Neurosurgery, University
Medical Center Regensburg, Regensburg, Germany, 3Department of Neurology, St. Josef Hospital, Moers, Germany,
4Department of Neurology, General Hospital Helios Klinikum Erfurt, Erfurt, Germany, 5Department of Neurosurgery, University
Medical Center Ulm, Ulm, Germany, 6Center for Clinical Studies, University Medical Center Regensburg, Regensburg,
Germany, 7Neurology, Department of Neurology and Institution for Translational Neurology, Münster, Germany, 8 Stroke
Center Hirslanden, Klinik Hirslanden Zurich, Zurich, Switzerland
Background and Purpose: Acute intracerebral hemorrhage (ICH) requires rapid
decision making toward neurosurgery or conservative neurological stroke unit treatment.
In a previous study, we found overestimation of clinical symptoms when clinicians rely
mainly on cerebral computed tomography (cCT) analysis. The current study investigates
differences between neurologists and neurosurgeons estimating specific scores and
clinical symptoms.
Methods: Overall, 14 neurologists and 15 neurosurgeons provided clinical estimates
and National Institutes of Health Stroke Scale (NIHSS) as well as Glasgow Coma Scale
(GCS) based on cCT images and basic information of 50 patients with hypertensive and
lobar ICH. Subgroup analyses were performed for the different professions (neurologists
vs. neurosurgeons) and bleeding subtypes (typical location vs. atypical). The differences
between the actual GCS and NIHSS scores and the cCT-imaging-based estimated
scores were depicted as Bland–Altman plots and negative and positive predictive value
(NPV and PPV) for prediction of clinical relevant items. 1NIHSS points (1GCS points)
were calculated as the difference between actual and rated NIHSS (GCS) including 95%
confidence interval (CI).
Results: Mean 1GCS points for neurosurgeons was 1.16 (95% CI: −2.67–4.98);
for neurologists, 0.99 (95% CI: −2.58–4.55), p = 0.308; mean 1NIHSS points for
neurosurgeons was −2.95 (95% CI: −12.71–6.82); for neurologists, −0.33 (95% CI:
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−9.60–8.94), p < 0.001. NPV and PPV for stroke symptoms were low, with large
differences between different symptoms, bleeding subtypes, and professions. Both
professions had more problems in proper rating of specific clinic–neurological symptoms
than rating scores.
Conclusion: Our results stress the need for joint decision making based on detailed
neurological examination and neuroimaging findings also in telemedicine.
Keywords: intracerebral hemorrhage, Glasgow coma scale, national institutes of health stroke scale, computed
tomography, cerebral amyloid angiopathy, quality of life, outcome, telestroke
INTRODUCTION
Spontaneous intracerebral hemorrhages (ICHs) account for 10–
15% of all strokes in Western populations, with a case fatality
of 40−55% (1). Although treatment options are limited and
neurosurgery is restricted to reducing mortality, rapid decision
making is crucial for the individual patient. In stroke treatment,
telemedical networks increasingly fill the void of specialized
neurovascular centers and organize neurosurgical or neurological
treatment. Cerebral computed tomography (cCT) images are
primarily transferred to the specialist via telemedicine and
ICH is easily identified as the cerebral pathology. Significant
predictive outcome factors for ICH include the volume of blood
on the initial cCT scan, presence, and ongoing expansion of
intraventricular hemorrhage (IVH), hematoma location, and
expansion and the neurological status (2). Further relevant
predictors for outcome and functional independence after 100
days are the patient’s age and the National Institutes of Health
Stroke Scale (NIHSS) score at initial presentation, regardless of
the location of the ICH (3, 4).
Often, patients are initially seen in primary care hospitals
lacking specific neurological or neurosurgical departments.
Non-specialized neurological examinations are increasingly
followed by reading a patient’s cCT imaging via teleradiologic
consultation. In the case of ischemic stroke, the decision
to conduct thrombolysis or even endovascular treatment
basically relies on the NIHSS score, a cCT scan excluding
ICH, an appropriate time window and the status of the
arteries leading to the brain (5). In acute stroke therapy,
telemedicine has been established in Germany in networks
like the TeleMedical Project for integrative Stroke Care
(TEMPiS) in Bavaria, Germany, for 15 years now and has
significantly increased the rate of treated strokes and transient
ischemic attacks as well as decreased the onset-to-treatment
and door-to-needle time in clinically underserved areas
(6). For clinical decision making, e.g., in thrombolysis,
teleradiology using electronically transmitted original
imaging data has to be completed by teleconsultation by
a remotely located expert through the use of high-quality
videoconferencing (7). The same concept could also be used
for the first neurological consultation of patients with ICH in
rural areas.
Especially in rural areas not having established telemedicine,
often specialists in the tertiary centers are called by the local
physicians and asked for their opinion without being able to do
an examination of the patient by themselves—or patients have to
be transferred to a center.
In a previous study we demonstrated that rating NIHSS
and Glasgow Coma Scale (GCS) score merely according
to the patients’ cCT leads to underestimation of GCS and
overestimation of NIHSS score, indicating that the patients’
clinical symptoms were overestimated. This effect was
particularly apparent in patients with lobar bleedings (8).
The main objective of the present analysis was to evaluate
possible differences between neurologists and neurosurgeons in
estimation of patients’ GCS and NIHSS score.
MATERIALS AND METHODS
Twenty board-certified neurologists and 20 board-certified
neurosurgeons were given the anonymized files of the initial
diagnostic cCT scans of 50 patients with an acute neurological
TABLE 1 | Questionnaire on the patients’ symptoms to be filled in by the
physicians merely on the basis of the patients’ basic characteristics (age, sex,
time between symptom onset, and initial cCT scan) shown in Table 1 and the
patients’ initial cCT scans (English translated version).
Symptom Yes No
Reduced level of consciousness 1 1
Gaze palsy or forced deviation 1 1
Anisocoria 1 1
Mild impairment of orientation 1 1
Severe impairment of orientation 1 1
Aphasia/dysarthria 1 1
Neglect (extinction and inattention) 1 1
Mild paralysis 1 1
Partial paralysis 1 1
Complete paralysis 1 1
Sensory loss 1 1
Facial palsy 1 1
Hemianopia 1 1
Double vision 1 1
Limb ataxia 1 1
Stance and gait ataxia 1 1
Babinski’s sign present 1 1
Elevated tendon reflexes 1 1
NIHSS GCS
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TABLE 2 | Patient characteristics: age, type of ICH [a = atypical (highlighted in blue), t = typical (highlighted in red)], time between symptom onset and initial cCT scan,
actual GCS/NIHSS score, medium GCS/NIHSS score estimated by the neurologists/neurosurgeons on the basis of the presented cCT scans and the basic information
on the patient, 1GCS/NIHSS score as the difference between actual and estimated GCS/NIHSS score.
Pati-ent Age
(years)
Type of
ICH
Time between
symptom onset and
initial cCT h
Actual
NIHSS
Medium
estimat-ed
NIHSS
(Absolute) 1
NIHSS
points
Actual GCS Medium
estimated
GCS
(Absolute) 1
GCS points
1 76–80 a 4.5–12 20 17.71 2.29 12 9.69 2.31
2 61–65 t >12 13 16.60 3.60 12 9.83 2.17
3 81–85 a 4.5–12 6 5.30 0.70 15 13.52 1.48
4 66–70 a >12 2 3.90 1.90 15 14.21 0.79
5 76–80 a <1.5 10 3.20 6.80 12 13.93 1.93
6 61–65 t >12 19 19.55 0.55 14 8.45 5.55
7 76–80 a >12 3 4.00 1.00 15 14.10 0.90
8 71–75 t <1.5 19 13.35 5.65 10 11.83 1.83
9 56–60 t 1.5–4.5 21 19.50 1.50 8 8.97 0.97
10 71–75 t >12 4 7.95 3.95 15 13.96 1.04
11 41–45 t >12 15 11.90 3.10 15 12.90 2.10
12 71–75 a <1.5 12 7.16 4.84 15 12.85 2.15
13 86–90 t >12 1 6.15 5.15 13 14.00 1.00
14 81–85 a >12 7 11.45 4.45 11 12.07 1.07
15 81–85 a 4.5–12 4 6.60 2.60 14 13.62 0.38
16 61–65 a <<1.5 4 4.80 0.80 15 13.97 1.03
17 56–60 a <1.5 4 12.70 8.70 11 11.69 0.69
18 81–85 a >12 24 14.10 9.90 11 11.52 0.52
19 66–70 a 4.5–12 13 13.30 0.30 15 11.14 3.86
20 91–95 t 1.5–4.5 12 11.68 0.32 10 12.41 2.41
21 71–75 a 1.5–4.5 3 3.20 0.20 15 14.52 0.48
22 96–100 a 1.5–4.5 20 25.90 5.90 7 5.52 1.48
23 91–95 t 1.5–4.5 7 15.45 8.45 14 10.90 3.10
24 66–70 a 1.5–4.5 16 20.85 4.85 10 7.45 2.55
25 86–90 t 1.5–4.5 16 18.05 2.05 15 10.79 4.21
26 81–85 a <1.5 4 15.75 11.75 13 10.96 2.04
27 76–80 t <1.5 22 22.53 0.53 8 7.78 0.22
28 66–70 a <1.5 7 6.21 0.79 15 14.11 0.89
29 66–70 a >12 3 5.70 2.70 15 13.96 1.04
30 61–65 a 4.5–12 3 7.35 4.35 15 13.82 1.18
31 71–75 a 1.5–4.5 11 13.00 2.00 15 11.54 3.46
32 51–55 t <1.5 11 10.42 0.58 15 13.70 1.30
33 71–75 t <1.5 23 22.10 0.90 8 9.07 1.07
34 76–80 a 4.5–12 4 8.80 4.80 13 13.68 0.68
35 36–40 t 1.5–4.5 25 22.55 2.45 8 7.75 0.25
36 81–85 t 4.5–12 8 11.15 3.15 15 13.43 1.57
37 66–70 t <1.5 14 20.85 6.85 13 9.14 3.86
38 51–55 t 4.5–12 9 6.60 2.40 15 14.36 0.64
39 66–70 t <1.5 13 16.45 3.45 15 9.86 5.14
40 86–90 t 4.5–12 27 20.45 6.55 7 7.64 0.64
41 61–65 t 4.5–12 11 11.20 0.20 14 13.29 0.71
42 71–75 t >12 4 10.10 6.10 14 13.07 0.93
43 51–55 t >12 3 8.25 5.25 15 13.68 1.32
44 71–75 a >12 2 7.40 5.40 13 13.57 0.57
45 76–80 t 1.5–4.5 8 9.95 1.95 15 13.86 1.14
46 76–80 a >12 15 8.00 7.00 14 12.70 1.30
47 56–60 t >12 12 15.50 3.50 14 11.39 2.61
48 66–70 a >12 3 3.70 0.70 15 14.39 0.61
49 61–65 a 4.5–12 2 11.65 9.65 15 11.21 3.79
50 51–55 t 1.5–4.5 22 13.10 8.90 10 12.64 2.64
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deficit from ICH. No group of physicians was animated to do a
special GCS or NIHSS training before participating in our study.
Neurologists and neurosurgeons were blinded to the patients’
specific clinical features but only given information about age
of the patients and lapse of onset to scan, with the scan—apart
from rare exceptions, e.g., in patients who came delayed and
with an unusual anamnesis—being performed in the emergency
department at latest 30min after the patient’s arrival, and were
asked to estimate clinical symptoms (Table 1: questionnaire on
the patients’ symptoms to be filled in by the physicians) as well
as the NIHSS and GCS score according to the cCT scan and the
aforementioned basic clinical information. In the questionnaire
are included basically the symptoms also found in the NIHSS
score, but in a version also useable for the neurosurgeons not
as used to NIHSS as neurologists. Therefore, we did not ask
to graduate, e.g., hemiparesis like in the NIHSS score with 0–
4 points but in absent–mild–severe—or even hemiplegia. We
added items not included in the NIHSS score, but relevant to
our everyday clinical treatment of ICH patients like anisocoria,
reflexes, or the Babinski sign.
The answers for the questionnaire, the physicians
(neurologists and neurosurgeons) had to fill in, were sent back
anonymized and we thus had no possibility to draw conclusions
on any specified persons filling in these questionnaires.
According to the “(Model) Professional Code for Physicians in
Germany–MBO-Ä 1997—The Resolutions of the 114th German
Medical Assembly 2011 in Kiel as amended by the 118th
German Medical Assembly 2015 in Frankfurt am Main, Art. 15-
3 Research” performing research in Germany, you do not need
an explicit vote of the ethic committee if you do not use person-
specific data. For the same reason we decided not to obtain
written consent of the participants. The participants were given
oral and written information about the design and the aim of the
study including anonymization.
TABLE 3 | Age (in age ranges of 5 years) and years of experience of board-certified neurologists and neurosurgeons—raw data.
Physician (neur.,neurologist;
n.surg. own, neurosurgeon
from own hospital; n.surg.
other, neurosurgeon from
other hospital)
Group of physician (neur.,
neurologist; n.surg. own,
neurosurgeon from own
hospital; n.surg.other,
neurosurgeon from other
hospital)
Age Years of practice after
becoming board-certified
neurologist/neurosurgeon
Years of leading a stroke unit
(neurologists only)/number of
operated ICH as
board-certified neurosurgeon
(neurosurgeons only)
neur. 1 neur. 51–55 22 0
neur. 2 neur. 41–45 12 6
neur. 3 neur. 36–40 5 2
neur. 4 neur. 36–40 5 1
neur. 5 neur. 51–55 16 9
neur. 6 neur. 36–40 5 1
neur. 7 neur. 46–50 15 8
neur. 8 neur. 51–55 16 10
neur. 9 neur. 41–45 10 10
neur. 10 neur. 51–55 16 12
neur. 11 neur. 46–50 10 0
neur. 12 neur. 41–45 8 3
neur. 13 neur. 41–45 5 4
neur. 14 neur. 46–50 12 0
n.surg. own 1 n.surg. own n.a. n.a. n.a.
n.surg. own 2 n.surg. own n.a. n.a. n.a.
n.surg. own 3 n.surg. own 36–40 1 30
n.surg. own 4 n.surg. own 36–40 5 150
n.surg. own 5 n.surg. own 61–65 26 100
n.surg. own 6 n.surg. own 36–40 1.5 50
n.surg. own 7 n.surg. own 31–35 1 60
n.surg. own 8 n.surg. own 41–45 9 200
n.surg. own 9 n.surg. own 46–50 20 100
n.surg. own 10 n.surg. own 51–55 17 200
n.surg. other 1 n.surg. other 41–45 5 50
n.surg. other 2 n.surg. other 41–45 10 70
n.surg. other 3 n.surg. other 31–35 3 30
n.surg. other 4 n.surg. other 36–40 7 50
n.surg. other 5 n.surg. other 36–40 5 20
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Of the included patients, 25 suffered from an acute
symptomatic deep, likely hypertensive, ICH in typical location
as basal ganglia, pons, or cerebellum also classified as (deep)
“typical” ICH due to the location (9). In an additional 25 patients,
cCT scans depicted symptomatic lobar ICH in atypical location,
therefore classified as “atypical” ICH. Patients suffering from ICH
with other causes of ICH such as excessive administration of
a vitamin K antagonist (defined as INR > 3), antecedent head
trauma or ischemic stroke, CNS tumor, vascular malformation,
vasculitis, blood dyscrasia, or coagulopathy were excluded (10).
Patients with lobar ICH were only included if they had possible
or probable cerebral amyloid angiopathy (CAA) according to
the modified Boston criteria (11). These patients routinely
underwent MRI (including FLAIR and T2∗ susceptibility
sequences) with MR-angiography or CT-angiography later on to
rule out any vasculopathy and to detect microbleedings or lobar
bleeds in cortical regions or cortical superficial siderosis, which
defines probable CAA in the later course of the disease (11).
Median age of the patients was 71 years (range: 39–97 years) and
26/50 were female. Time from symptom onset to initial cCT-
imaging was <1.5 h in 12 patients, 1.5 to 4.5 h in 11 patients,
4.5 to 12 h in 11 patients, and more than 12 h in 16 patients
(see Table 2). The patient data were only used in anonymized
form to present them to the physicians, and the study did not
affect individual patient treatment. Therefore, neither local ethic
approval nor patient consent deemed necessary. All raters were
informed about their participation in a study.
The GCS and NIHSS scores rated by the physicians were
compared to those calculated on the basis of the patients’
medical records and clinical features reported in the patients’
medical records at admission (here called “actual GCS/NIHSS”)
analogous to Williams et al. (12). Mean 1GCS points and mean
1NIHSS points were defined as the difference between the actual
GCS/NIHSS minus the rated GCS/NIHSS [1GCS points = GCS
points (actual)—GCS points (rater); 1NIHSS points = NIHSS
points (actual) – NIHSS points (rater)].
FIGURE 1 | (A–C) The Bland–Altman plots show the difference between the actual and the estimated GCS score (mean for all raters) on patient basis: The mean
estimated GCS score is too low by 1.07 GCS points (A). (B,C) Subgroup analyses for estimated GCS score in neurosurgeons as well as neurologists, showing mean
estimated scores too low by 1.16 and 0.99 GCS points, respectively. (D–F) The Bland–Altman plots show the difference between the actual and the estimated NIHSS
score (mean for all raters) on patient basis: The median estimated NIHSS score is too high by 1.24 NIHSS points (D). (E,F) Subgroup analyses. Neurologists
overestimate NIHSS scores by 0.33 points, neurosurgeons by 2.95 points.
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Agreement between the actual and estimated NIHSS and
GCS scores was evaluated on an individual patient basis, i.e.,
the patient’s actual value was compared with one estimated
value and calculated as the mean value of the estimate by
all neurologists and neurosurgeons. The extent of agreement
between the estimated and the actual NIHSS and GCS scores
was quantified with the Bland–Altman plot (13). According to
Krouwer (14), the actual NIHSS or GCS values rather than the
average value were used on the X-axis. All plots include the
mean difference, the 95% limits of confidence, and the regression
line. All analyses were performed using R (version 3.3.3, The R
Foundation for Statistical Computing).
In a next step, we analyzed whether or not neurological
symptoms related to ICH existed that were easy to predict
on the basis patients’ cCT and basic clinical information only.
Furthermore, we investigated whether a specific symptom can be
predicted as present or absent.
Therefore, we calculated negative and positive predictive value
(NPV and PPV) of the patients’ symptoms on a single-item
basis. PPV was defined as the probability that the patient in fact
presented a symptom if the physician estimated the symptom
to be present on the basis of the patient’s cCT scan. NPV was
defined as the probability that the physician predicted a symptom
correctly as being absent. Furthermore, we performed subgroup
analyses for neurologists vs. neurosurgeons and atypical vs.
TABLE 4 | NPV and PPV on a single-item basis (all types of ICH in all raters): Left
column of the table showing the PPV with which the raters could predict a
symptom, i.e., how likely it was that a patient in fact showed a symptom when the
physician estimated the patient to have the symptom.
PPV NPV
Double vision 0.03 Hemihypesthesia 0.49
Anisocoria 0.10 Facial paresis 0.59
Ataxia of gait 0.31 Tendon reflexes
reduced/elevated
0.64
Dysmetria 0.32 Reduced level of consciousness 0.65
Hemiplegia 0.33 Mild impairment of orientation 0.66
Mild impairment of
orientation
0.35 Mild hemiparesis 0.69
Eye and head version 0.37 Severe hemiparesis 0.69
Severe hemiparesis 0.39 Babinski’s sign present 0.71
Neglect 0.40 Neglect 0.72
Tendon reflexes
reduced/elevated
0.42 Eye and head version 0.75
Mild hemiparesis 0.48 Dysmetria 0.75
Hemihypesthesia 0.48 Aphasia 0.77
Severe impairment of
orientation
0.53 Severe impairment of orientation 0.79
Babinski’s sign present 0.54 Scotoma 0.82
Scotoma 0.56 Ataxia of gait 0.83
Facial paresis 0.63 Hemiplegia 0.85
Aphasia 0.64 Anisocoria 0.90
Reduced level of
consciousness
0.74 Double vision 0.97
Right column of the table showing the NPV, i.e., how likely the symptom was absent when
raters estimated it to be absent (highlighted in blue: NPV or PPV > 0.70, highlighted in
red: NPV or PPV > 0.80, highlighted in green: NPV or PPV > 0.90).
typical ICH using the same methods as described for the
indicated subgroup. A PPV or NPV ≥ 0.7 was defined as
acceptable by empirical reasons, a PPV or NPV > 0.8 as good,
a PPV or NPV> 0.9 as very good.
RESULTS
Fourteen of 20 (70%) neurologists and 15 of 20 (75%)
neurosurgeons addressed answered our questionnaire (see
Table 3 for physician baseline data). The actual mean GCS score
of the total ICHpatient collective was 14 [standard deviation (SD)
2.5; range 7–15], and the actual mean NIHSS score was 10 (SD
7.3; range 1–27) (Table 2).
On average, GCS was rated too low by 1.07 points by all raters,
with slightly lower results for neurosurgeons (mean1GCS points
1.16; 95% CI: −2.67, 4.98) than for neurologists (mean 1GCS
points: 0.99; 95%CI:−2.58, 4.55), p= 0.308 (Figures 1A–C). The
NIHSS score estimated on the basis of the cCT correlated better
with the actual values when rating was performed by neurologists
(mean 1NIHSS points: −0.33; 95% CI: −9.60, 8.94), than by
neurosurgeons (mean 1NIHSS points: −2.95; 95% CI: −12.71,
6.82; p < 0.001; for all raters: 1.24). Here, also the large CIs
for all groups of physicians (all: 18.45; neurosurgeons: 19.53;
neurologists: 18.54) reflected the challenge of properly estimating
the patients’ symptoms (Figures 1D–F).
Level of consciousness was the only item with a PPV > 0.7
in both groups of physicians (PPV = 0.74, Table 4). The lowest
PPV observed were double vision, which the physicians failed to
predict in >95% of cases (PPV 0.03) and anisocoria with a PPV
of 0.10.
The NPV, i.e., exclusion of symptoms based on cCT, were also
relatively low with merely half of items correctly rated with a
NPV of more than 0.7 and only 1/6 of items correctly rated with
a NPV of more than 0.8 (Table 4). Only the symptoms double
vision and anisocoria could be sufficiently excluded [NPV= 0.97
and 0.90, respectively (Table 4)]. One of the most important
neurological symptoms—reduced level of consciousness—did
not reach a NPV of>0.7 (NPV 0.65) (Table 4).
In order to decipher differences for typical vs. atypical ICH,
we analyzed differences of PPV and NPV on a single-item
basis (Tables 5A,B). The results were inhomogeneous with items
reaching better results in scoring patients with either typical or
atypical ICH. For the item aphasia as an example, a PPV of 0.76
for atypical ICH was reached (as opposed to <0.7 for typical
ICH). In contrast, the item facial paresis had a PPV of 0.71 for
typical ICH and<0.7 for atypical ICH (Tables 5A,B).
In general, NPV for neurological symptoms was better when
rating atypical ICH than typical ICH for most items. Differences
reached up to 15% between the two groups (Table 5B). The only
two exceptions were mild hemiparesis (NPV for typical ICH
0.77, NPV for atypical ICH < 0.7) and severe impairment of
orientation (NPV for typical ICH 0.79, NPV for atypical ICH
0.78), which reached a higher NPV in patients with typical ICH.
Level of consciousness in that subgroup analysis only
reached a NPV of 0.70 for atypical ICH vs. < 0.70 in typical
ICH (Table 5B).
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TABLE 5 | Subgroup analysis of PPV (A) and NPV (B) for atypical vs. typical ICH (data only shown for NPV or PPV > 0.70) (highlighted in blue: NPV or PPV > 0.70,
highlighted in red: NPV or PPV > 0.80, highlighted in green: NPV or PPV > 0.90).
Symptom Typical ICH Atypical ICH PPV typical ICH > atypical ICH PPV atypical ICH > typical ICH
(A) PPV > 0.70
Facial paresis 0.71 <0.70 X
Reduced level of consciousness 0.74 0.72 X
Aphasia <0.70 0.76 X
Symptom Typical ICH Atypical ICH NPV typical > atypical NPV atypical > typical
(B) NPV > 0.70
Reduced level of consciousness <0.70 0.70 X
Eye and head version 0.72 0.81 X
Tendon reflexes reduced/elevated <0.70 0.74 X
Neglect <0.70 0.75 X
Hemiplegia 0.76 0.92 X
Mild hemiparesis 0.77 <0.70 X
Dysmetria <0.70 0.78 X
Severe impairment of orientation 0.79 0.78 X
Scotoma 0.79 0.85 X
Aphasia <0.70 0.82 X
Severe hemiparesis <0.70 0.82 X
Babinski’s sign present <0.70 0.84 X
Anisocoria 0.85 0.96 X
Ataxia of gait <0.70 0.88 X
Double vision 0.96 0.97 X
Comparing neurologists and neurosurgeons, the PPV of
neurologists were overall higher with four items >0.7. For
neurosurgeons, only the item “level of consciousness” had a PPV
> 0.7 (Table 6A). There was a slight trend for better rating of
NPV by neurosurgeons than neurologists. Interestingly, rating
the level of consciousness reached a NPV > 0.7 only in the
group of neurologists [NPV 0.70 for neurologists, < 0.7 for
neurosurgeons (Table 6B)].
Differences of more than 10% in rating NPV and PPV between
neurologists and neurosurgeons are shown in Table 7.
DISCUSSION
In this study, we demonstrate distinct differences in estimating
GCS and NIHSS scores based on cCT scan analysis among
neurologists and neurosurgeons in ICH patients. In general,
physicians had more problems in proper rating of specific
clinical–neurological symptoms than of GCS and NIHSS
scores. This scenario is often present in telemedical and
even more pure teleradiological networks and may lead to
unnecessary or erroneous transfer of patients stressing the
need for joint decision making on the basis of thorough
neurological investigation and communication. Even in
hemorrhagic stroke, which is readily depicted on cCT, clinical
neurological assessment cannot be replaced, as previously
demonstrated (8).
The only clinical item that could be predicted with a PPV >
0.7, i.e., 70% correct prediction, was the level of consciousness,
which is critical for intubation and thus of particular relevance,
including outcome (2, 15–17). In the subgroup of atypical ICH,
aphasia could be predicted with a PPV of 0.76. This is probably
due to the relatively well-defined cortical presentation of the
language-relevant structures resulting in aphasia. Especially in
smaller ICH, eloquent areas are damaged more frequently by
atypical than by typical ICH. In the subgroup of typical ICH,
facial paresis reached a PPV of 0.71. Interestingly, this contrasts
a former study showing that indeed facial paresis is quite hard
to detect correctly even in clinical examination (18). A possible
explanation is that brachiofacial hemiparesis is quite often due to
damage of the white matter, the main location of typical ICH not
only in our study, making a correct estimation of this symptom
more likely.
The excellent NPV of 0.97 for double vision (in 97% of patients
double vision was correctly excluded) may also result from the
well-defined anatomical location of corresponding lesions in
the brainstem or pons. Similarly, lesions causing anisocoria,
also associated with a NPV of 0.9, typically involve brainstem
or diencephalic lesions. This is of importance as unilateral
dilation in an ICH patient is indicative for temporal herniation,
is accompanied with a low GCS, and calls for immediate
treatment [intubation, treatment in a (neuro-)intensive
department, immediate CT control, decompressive
surgery] (19–21).
Of the 11 of total 18 symptoms with a NPV > 0.7, 10
symptoms were associated with a PPV<0.6 (see Table 8). For 12
symptoms, PPV was even below 0.5, which would be expected
for mere guessing. This indicates for a possible bias toward
overestimation of symptoms by the rating physicians. The NPV
was higher than PPV for 16 of the 18 symptoms. This also is in
agreement with our former study, where we already showed that
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TABLE 6 | Subgroup analysis of PPV (A) and NPV (B) for neurologists vs. neurosurgeons (data only shown for NPV/PPV > 0.70) [highlighted in blue: NPV or PPV > 0.70,
highlighted in red: NPV or PPV > 0.80, highlighted in green: NPV > 0.90 (for PPV: data >0.90 n.a.)].
Symptom Neurologist (neur.) Neurosurgeon (n.surg.) PPV neur. > n.surg. PPV n.surg. > neur.
(A) PPV > 0.70
Reduced level of consciousness 0.75 0.72 X
Babinski’s sign present 0.72 <0.70 X
Facial paresis 0.81 <0.70 X
Aphasia 0.83 <0.70 X
Symptom Neurologist Neurosurgeon NPV neur. > n.surg. NPV n.surg. > neur.
(B) NPV > 0.70
Reduced level of consciousness 0.70 <0.70 X
Severe hemiparesis <0.70 0.70 X
Dysmetria 0.78 0.72 X
Eye and head version 0.76 0.73 X
Facial paresis <0.70 0.74 X
Ataxia of gait 0.89 0.76 X
Scotoma 0.78 0.86 X
Severe impairment of orientation 0.78 0.79 X
Neglect <0.70 0.80 X
Tendon reflexes reduced/elevated <0.70 0.80 X
Babinski’s sign present <0.70 0.82 X
Hemiplegia 0.88 0.83 X
Anisocoria 0.89 0.91 X
Aphasia <0.70 0.91 X
Double vision 0.96 0.98 X
in rating GCS and NIHSS scores, physicians overestimated the
patients’ symptoms (8).
Overestimation of symptoms may lead to more inappropriate
transfers of patients to tertiary centers or to neurosurgical
departments posing medical, economical, and ethical problems.
Any transfer of a severely ill patient carries an inherent medical
risk and should be avoided and likewise surgical treatment
should be based on relevant information to be outweighted
with the operative risks. A recently published, retrospective
study examined which factors are associated with emergent
intervention during the first 24 h following helicopter transport
of ICH patients to a tertiary-level care center. Age, GCS, and clot
volume were detected as significant predictors of neurosurgical
intervention within 24 h after helicopter transport, whereas in
multivariate analysis, only younger age, GCS of 3–8, and lobar
hemorrhage were found to be independent predictors for surgery.
Interestingly, only 30.8% of the transferred patients had at least
one neurosurgical intervention (22). Another study indicated
that patients undergoing surgery have—even with similar ICHs—
a longer stay on ICU (intensive care unit) and on mechanical
ventilation (23). Patient transfers and surgery not indicated are
also associated with high costs, which would be better invested
in other medical treatments, e.g., for ensuing rehabilitation in
these patients.
On the other hand, besides the initial cCT, other criteria
like patient age and comorbidities are essential for the patient’s
prognosis, and in certain constellations, these criteria may lead
to transfer even of a patient with only a minor ICH in initial cCT
but a high risk for future deterioration due to secondary progress
of ICH or edema.
Neurologists and neurosurgeons use different scoring systems
in their everyday practice (8). Thus, the larger problems
neurosurgeons had in rating NIHSS score compared to
neurologists may be explained by the fact that both professions
are well-acquainted with GCS score, whereas NIHSS score is
typically used by clinical neurologists in everyday practice in
patients with an ischemic stroke, where the NIHSS is known as
a well-established score, also for the patients’ future prognosis.
Due to everyday practice, neurologists and neurosurgeons
may have different points of view on the same patient: For
the neurosurgeon, the most important question in emergency
situations is whether or not the patient should undergo surgery.
This is often decided depending on critical clinical signs such
as altered level of consciousness or anisocoria, indicating live-
threatening ICH. The other items may be more relevant to the
neurologist, who in his everyday practice is more interested in the
pathophysiologic background of the ICH as basis for adequate
secondary prevention and long-term outcome and therefore has
to be more aware also of minor deficits (24–27).
Several limitations of this study exist: first, the patient’s GCS
encompassed a range of 7–15 points, thus not representing the
entire range of clinical presentations, and not reflecting the
worst-case scenario in ICH. However, our spectrum of ICH
cases represents the group of patients with the most uncertain
prognosis, which may especially benefit from balanced decision
making. Patients with a GCS of 8 and lower are often intubated
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TABLE 7 | PPV (left column) and NPV (right column)—items with a difference of more than 10% in rating by neurologists vs. neurosurgeons.
PPV NPV
Symptom Neurologist Neurosurgeon PPV neur. >
n.surg
PPV n.surg
> neur.
Symptom Neurologist Neurosurgeon NPVneur.> n.
surg
NPV n.surg
> neur.
Severe impairment
of orientation
0.58 0.48 X Aphasia 0.65 0.91 X
Mild hemi
paresis
0.57 0.39 X Neglect 0.66 0.80 X
Facial paresis 0.81 0.42 X Hemihyp
estesia
0.31 0.69 X
Ataxia of gait 0.21 0.42 X Facial paresis 0.45 0.74 X
Babinski’s sign
present
0.72 0.34 X Ataxia of gait 0.89 0.76 X
Tendon reflexes
reduced/elevated
0.55 0.27 X Babinski’s
sign present
0.60 0.82 X
Tendon
reflexes
reduced/
elevated
0.50 0.80 X
TABLE 8 | Comparison of PPV and NPV on a single-item level [highlighted in blue: NPV or PPV > 0.70, highlighted in red: NPV > 0.80 (PPV n.a.), highlighted in green:
NPV > 0.90 (PPV n.a.)].
Symptom PPV NPV NPV > PPV NPV < PPV NPV > 70 PPV > 60
Double vision 0.03 0.97 X X
Anisocoria 0.10 0.90 X X
Ataxia of gait 0.31 0.83 X X
Dysmetria 0.32 0.75 X X
Hemiplegia 0.33 0.85 X X
Mild impairment of orientation 0.35 0.66 X
Eye and head version 0.37 0.75 X X
Severe hemiparesis 0.39 0.69 X
Neglect 0.40 0.72 X X
Tendon reflexes reduced/elevated 0.42 0.64 X
Mild hemiparesis 0.48 0.69 X
Hemihypesthesia 0.48 0.49 X
Severe impairment of orientation 0.53 0.79 X X
Babinski’s sign present 0.54 0.71 X X
Scotoma 0.56 0.82 X X
Facial paresis 0.63 0.59 X X
Aphasia 0.64 0.77 X X X
Reduced level of consciousness 0.74 0.65 X X
already in the prehospital stage and have the highest probability
of neurosurgery. But both in the surgery and conservative group,
they have a very bad prognosis. Therefore, immediate palliative
care is sometimes decided in these patients, too (5, 27, 28).
In the two largest randomized trials comparing early
surgery (within 24 h of randomization) with medical treatment
for spontaneous supratentorial intracerebral hematomas
(STICH) and for spontaneous supratentorial lobar intracerebral
hematomas (STICH II), patients also were only included with
a GCS ≥ 5 (for STICH) and ≥7 (for STICH II), respectively
(27, 28). Patients in our study had a higher overall GCS than
in the STICH studies. For those, the inclusion criterion was
“the clinical uncertainty principle,” i.e., if the responsible
neurosurgeon was uncertain about the benefits of either
treatment, the patient was included in the study. STICH did not
show an overall benefit of early surgery, except for the subgroup
of patients with hematoma within 1 cm of cortical surface.
STICH II subsequently showed that early surgery might indeed
have a small but clinically relevant survival advantage for patients
with lobar ICH. The need for a rescue operation in the initial
conservative treatment group and outcome in both groups were
significantly correlated with initial clinical deficits of the patients.
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Both these and our study underline the importance of a good
clinical examination of the patients prior to a decision on surgery
(27, 28). The results are not strong enough to draw conclusions
for guidelines. Present expert consensus is to consider surgery in
superficial lobar clots, especially those larger than 30ml and as a
life-saving treatment in patients with GCS< 8 (5, 29).
Due to the small sample size, the statistical power of
our study is limited. However, each participant examined
cCT scans of 50 patients with completely more than 1,000
images for this study. As the acute decisions on patient
care are often up to neurologists/neurosurgeons without 24/7
neuroradiological competence available, we decided against
participation of neuroradiologists.
Furthermore, for the atypical ICH, only ICHs due
to CAA were included. Our attempt was to create a
more homogeneous collective of atypical ICH, better
comparable to the etiologically quite homogenous
collective of typical ICH. All the same, we cannot
exclude that the generalizability of the study is limited
by that.
As a further limitation, it can be discussed that the physicians
did not have to participate in a systematic NIHSS training.
Our study underlines the necessity for a thorough
neurological status in addition to the cCT scans despite the
acute nature of the disease, even more in patients with atypical
ICH, and the importance of multidisciplinary approach of
neurologists, neurosurgeons, and physicians experienced in
(neuro)radiology for best decision making.
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